IL1RAP | interleukin 1 receptor accessory protein | 3q28 | 0.331 | 0.474 | 0
|
CXCL8 | chemokine (C-X-C motif) ligand 8 | 4q13-q21 | 0.321 | 0.605 | 0
|
TNIP3 | TNFAIP3 interacting protein 3 | 4q27 | 0.319 | 0.436 | 0
|
SOCS3 | suppressor of cytokine signaling 3 | 17q25.3 | 0.318 | 0.571 | 0
|
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 6q23-q25 | 0.313 | 0.6 | 0
|
F3 | coagulation factor III (thromboplastin, tissue factor) | 1p22-p21 | 0.31 | 0.559 | 0
|
OSMR | oncostatin M receptor | 5p13.2 | 0.308 | 0.502 | 0
|
IFNGR1 | interferon gamma receptor 1 | 6q23-q24 | 0.307 | 0.564 | 0
|
PRDM1 | PR domain containing 1, with ZNF domain | 6q21 | 0.306 | 0.509 | 0
|
DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 4q32.3 | 0.306 | 0.43 | 0
|
CFLAR | CASP8 and FADD-like apoptosis regulator | 2q33-q34 | 0.306 | 0.518 | 0
|
KLF10 | Kruppel-like factor 10 | 8q22.3 | 0.305 | 0.524 | 0
|
STAT1 | signal transducer and activator of transcription 1, 91kDa | 2q32.2-q32.3 | 0.304 | 0.423 | 0
|
RND3 | Rho family GTPase 3 | 2q23.3 | 0.303 | 0.498 | 0
|
NAMPT | nicotinamide phosphoribosyltransferase | 7q22.3 | 0.302 | 0.581 | 0
|
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 14q23.2 | 0.302 | 0.547 | 0
|
PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 6q12 | 0.301 | 0.549 | 0
|
CCL20 | chemokine (C-C motif) ligand 20 | 2q36.3 | 0.299 | 0.566 | 0
|
SAMD9L | sterile alpha motif domain containing 9-like | 7q21.2 | 0.299 | 0.459 | 0
|
ZNF446 | zinc finger protein 446 | 19q13.43 | 0.298 | -0.403 | 0
|
MYO1B | myosin IB | 2q12-q34 | 0.298 | 0.475 | 0
|
SGK1 | serum/glucocorticoid regulated kinase 1 | 6q23 | 0.297 | 0.533 | 0
|
JAK2 | Janus kinase 2 | 9p24 | 0.297 | 0.506 | 0
|
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 4q24 | 0.297 | 0.516 | 0
|
PLSCR1 | phospholipid scramblase 1 | 3q23 | 0.296 | 0.416 | 0
|
NCK1 | NCK adaptor protein 1 | 3q21 | 0.296 | 0.458 | 0
|
CASP1 | caspase 1, apoptosis-related cysteine peptidase | 11q23 | 0.296 | 0.485 | 0
|
FRMD4B | FERM domain containing 4B | 3p14.2 | 0.295 | 0.465 | 0
|
FLJ37453 | | | 0.295 | -0.412 | 0
|
SOD2 | superoxide dismutase 2, mitochondrial | 6q25 | 0.294 | 0.508 | 0
|
SUSD6 | sushi domain containing 6 | 14q24.1 | 0.294 | 0.509 | 0
|
MCL1 | myeloid cell leukemia 1 | 1q21 | 0.291 | 0.533 | 0
|
SAMD9 | sterile alpha motif domain containing 9 | 7q21.2 | 0.291 | 0.422 | 0
|
DUSP7 | dual specificity phosphatase 7 | 3p21 | 0.29 | 0.384 | 5.41e-17
|
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 4q13.3 | 0.29 | 0.535 | 0
|
RNF217 | ring finger protein 217 | 6q22.33 | 0.288 | 0.425 | 0
|
MB21D1 | Mab-21 domain containing 1 | 6q13 | 0.287 | 0.424 | 0
|
IRF1 | interferon regulatory factor 1 | 5q23-q31 | 0.286 | 0.437 | 0
|
NAB1 | NGFI-A binding protein 1 (EGR1 binding protein 1) | 2q32.3-q33 | 0.285 | 0.5 | 0
|
DENND2C | DENN/MADD domain containing 2C | 1p13.2-p13.1 | 0.282 | 0.371 | 2.28e-15
|
UGCG | UDP-glucose ceramide glucosyltransferase | 9q31 | 0.281 | 0.525 | 0
|
HBEGF | heparin-binding EGF-like growth factor | 5q23 | 0.28 | 0.512 | 0
|
STX11 | syntaxin 11 | 6q24.1 | 0.28 | 0.504 | 0
|
SLPI | secretory leukocyte peptidase inhibitor | 20q13.12 | 0.28 | 0.414 | 0
|
NUDT16L1 | nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 | 16p13.3 | 0.279 | -0.344 | 3.67e-13
|
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 11q22.2-q22.3 | 0.278 | 0.374 | 1.33e-15
|
SOX7 | SRY (sex determining region Y)-box 7 | 8p22 | 0.277 | 0.501 | 0
|
LIMA1 | LIM domain and actin binding 1 | 12q13.12 | 0.276 | 0.381 | 1.6e-16
|
ADORA2B | adenosine A2b receptor | 17p12 | 0.276 | 0.455 | 0
|
IL36G | interleukin 36, gamma | 2q12-q21 | 0.275 | 0.287 | 1.93e-09
|
CXCL3 | chemokine (C-X-C motif) ligand 3 | 4q21 | 0.274 | 0.529 | 0
|
STAT4 | signal transducer and activator of transcription 4 | 2q32.2-q32.3 | 0.274 | 0.441 | 0
|
SERPINB4 | serpin peptidase inhibitor, clade B (ovalbumin), member 4 | 18q21.33 | 0.274 | 0.372 | 1.96e-15
|
PPIL2 | peptidylprolyl isomerase (cyclophilin)-like 2 | 22q11.21 | 0.274 | -0.36 | 2.3e-14
|
HCP5 | HLA complex P5 (non-protein coding) | 6p21.3 | 0.273 | 0.41 | 0
|
MOB3B | MOB kinase activator 3B | 9p21.1 | 0.273 | 0.451 | 0
|
ADAM11 | ADAM metallopeptidase domain 11 | 17q21.3 | 0.272 | -0.422 | 0
|
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 8p21 | 0.272 | 0.417 | 0
|
LYN | LYN proto-oncogene, Src family tyrosine kinase | 8q13 | 0.272 | 0.391 | 0
|
CFB | complement factor B | 6p21.33 | 0.272 | 0.409 | 0
|
INA | internexin neuronal intermediate filament protein, alpha | 10q24 | 0.271 | -0.373 | 1.55e-15
|
PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 10p15.1 | 0.27 | 0.476 | 0
|
SGMS2 | sphingomyelin synthase 2 | 4q25 | 0.27 | 0.455 | 0
|
PHLDB3 | pleckstrin homology-like domain, family B, member 3 | 19q13.31 | 0.268 | -0.412 | 0
|
RAP2B | RAP2B, member of RAS oncogene family | 3q25.2 | 0.268 | 0.45 | 0
|
DHRS11 | dehydrogenase/reductase (SDR family) member 11 | 17q12 | 0.267 | -0.443 | 0
|
KYNU | kynureninase | 2q22.2 | 0.267 | 0.376 | 8.16e-16
|
MCTP1 | multiple C2 domains, transmembrane 1 | 5q15 | 0.265 | 0.466 | 0
|
TTC39B | tetratricopeptide repeat domain 39B | 9p22.2 | 0.264 | 0.422 | 0
|
IL4R | interleukin 4 receptor | 16p12.1-p11.2 | 0.263 | 0.366 | 6.54e-15
|
IL22RA2 | interleukin 22 receptor, alpha 2 | 6q24.1-q24.2 | 0.262 | 0.381 | 1.52e-16
|
HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 6p24-p22.3 | 0.262 | 0.461 | 0
|
GFI1 | growth factor independent 1 transcription repressor | 1p22 | 0.261 | 0.397 | 0
|
OAS3 | 2'-5'-oligoadenylate synthetase 3, 100kDa | 12q24.2 | 0.261 | 0.328 | 4.71e-12
|
BCL10 | B-cell CLL/lymphoma 10 | 1p22 | 0.261 | 0.415 | 0
|
PDZK1IP1 | PDZK1 interacting protein 1 | 1p33 | 0.261 | 0.406 | 0
|
CXCL2 | chemokine (C-X-C motif) ligand 2 | 4q13.3 | 0.26 | 0.519 | 0
|
TAPBPL | TAP binding protein-like | 12p13.31 | 0.26 | 0.31 | 7.12e-11
|
BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 11q13.1 | 0.259 | 0.38 | 2.64e-16
|
XDH | xanthine dehydrogenase | 2p23.1 | 0.258 | 0.355 | 5.11e-14
|
CTAGE5 | CTAGE family, member 5 | 14q21.1 | 0.258 | 0.384 | 4.44e-17
|
CDK17 | cyclin-dependent kinase 17 | 12q23.1 | 0.258 | 0.355 | 5.13e-14
|
CTTNBP2 | cortactin binding protein 2 | 7q31 | 0.258 | -0.194 | 5.38e-05
|
BIRC3 | baculoviral IAP repeat containing 3 | 11q22 | 0.257 | 0.491 | 0
|
CD59 | CD59 molecule, complement regulatory protein | 11p13 | 0.256 | 0.379 | 3.1e-16
|
STOM | stomatin | 9q34.1 | 0.255 | 0.445 | 0
|
MYC | v-myc avian myelocytomatosis viral oncogene homolog | 8q24 | 0.255 | 0.475 | 0
|
SPAG4 | sperm associated antigen 4 | 20q11.2 | 0.254 | -0.367 | 5.28e-15
|
MET | MET proto-oncogene, receptor tyrosine kinase | 7q31 | 0.254 | 0.337 | 1.07e-12
|
CSF3 | colony stimulating factor 3 (granulocyte) | 17q11.2-q12 | 0.254 | 0.435 | 0
|
UBAP1 | ubiquitin associated protein 1 | 9p13.3 | 0.253 | 0.396 | 0
|
VNN3 | vanin 3 | 6q23.2 | 0.253 | 0.471 | 0
|
SLC22A4 | solute carrier family 22 (organic cation/zwitterion transporter), member 4 | 5q23.3 | 0.252 | 0.456 | 0
|
CYB5R4 | cytochrome b5 reductase 4 | 6q14.2 | 0.252 | 0.358 | 2.9e-14
|
CREBL2 | cAMP responsive element binding protein-like 2 | 12p13.2 | 0.252 | 0.295 | 6.19e-10
|
OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 12q24.2 | 0.252 | 0.336 | 1.26e-12
|
ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 22q13.2 | 0.251 | 0.344 | 3.54e-13
|
CLCA3P | chloride channel accessory 3, pseudogene | 1p22.3 | 0.251 | 0.273 | 1.2e-08
|
SLC35D1 | solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1 | 1p31.3 | 0.25 | 0.366 | 6.82e-15
|
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 5q11.2 | 0.25 | 0.405 | 0
|
NT5DC2 | 5'-nucleotidase domain containing 2 | 3p21.1 | 0.249 | -0.429 | 0
|
HES6 | hes family bHLH transcription factor 6 | 2q37.3 | 0.248 | -0.364 | 1.02e-14
|
MAFG-AS1 | MAFG antisense RNA 1 (head to head) | 17q25.3 | 0.248 | -0.346 | 2.56e-13
|
PTPRK | protein tyrosine phosphatase, receptor type, K | 6q22.2-q22.3 | 0.248 | 0.42 | 0
|
PER2 | period circadian clock 2 | 2q37.3 | 0.248 | 0.421 | 0
|
AHCYL2 | adenosylhomocysteinase-like 2 | 7q32.1 | 0.247 | 0.311 | 6.17e-11
|
IER3 | immediate early response 3 | 6p21.3 | 0.247 | 0.539 | 0
|
GPT2 | glutamic pyruvate transaminase (alanine aminotransferase) 2 | 16q12.1 | 0.245 | -0.333 | 2.16e-12
|
HDDC3 | HD domain containing 3 | 15q26.1 | 0.244 | -0.381 | 1.85e-16
|
MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | 5q11.2 | 0.243 | 0.315 | 3.76e-11
|
CDC42SE2 | CDC42 small effector 2 | 5q31.1 | 0.243 | 0.377 | 5.3e-16
|
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 2q33-q34 | 0.242 | 0.366 | 6.56e-15
|
PTN | pleiotrophin | 7q33 | 0.241 | -0.214 | 8.49e-06
|
PICALM | phosphatidylinositol binding clathrin assembly protein | 11q14 | 0.239 | 0.302 | 2.37e-10
|
S100A7 | S100 calcium binding protein A7 | 1q21 | 0.239 | 0.218 | 5.51e-06
|
SLC29A4 | solute carrier family 29 (equilibrative nucleoside transporter), member 4 | 7p22.2 | 0.239 | -0.301 | 2.74e-10
|
RNF144B | ring finger protein 144B | 6p22.3 | 0.238 | 0.415 | 0
|
SAT1 | spermidine/spermine N1-acetyltransferase 1 | Xp22.1 | 0.238 | 0.366 | 6.65e-15
|
FABP3 | fatty acid binding protein 3, muscle and heart | 1p33-p32 | 0.237 | -0.163 | 0.000726
|
KCNG1 | potassium channel, voltage gated modifier subfamily G, member 1 | 20q13 | 0.236 | -0.344 | 3.69e-13
|
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 19p13.3 | 0.236 | -0.299 | 3.61e-10
|
ARMCX6 | armadillo repeat containing, X-linked 6 | Xq21.33-q22.3 | 0.235 | -0.326 | 6.77e-12
|
INPP1 | inositol polyphosphate-1-phosphatase | 2q32 | 0.235 | 0.403 | 0
|
PEX3 | peroxisomal biogenesis factor 3 | 6q24.2 | 0.235 | 0.382 | 1.15e-16
|
WTAP | Wilms tumor 1 associated protein | 6q25-q27 | 0.235 | 0.413 | 0
|
ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 | 21q22.3 | 0.234 | 0.481 | 0
|
SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 4q21.3-q22 | 0.233 | 0.363 | 1.13e-14
|
ZSWIM6 | zinc finger, SWIM-type containing 6 | 5q12.1 | 0.232 | 0.324 | 9.05e-12
|
AIM1 | absent in melanoma 1 | 6q21 | 0.231 | 0.397 | 0
|
CLIP4 | CAP-GLY domain containing linker protein family, member 4 | 2p23 | 0.231 | 0.422 | 0
|
RNF114 | ring finger protein 114 | 20q13 | 0.23 | 0.18 | 0.000186
|
LY75 | lymphocyte antigen 75 | 2q24 | 0.23 | 0.215 | 8.06e-06
|
FSCN2 | fascin actin-bundling protein 2, retinal | 17q25 | 0.229 | -0.356 | 4.48e-14
|
CARD10 | caspase recruitment domain family, member 10 | 22q13.1 | 0.229 | 0.332 | 2.38e-12
|
ZNHIT3 | zinc finger, HIT-type containing 3 | 17q21.1 | 0.227 | -0.36 | 2.17e-14
|
SAA4 | serum amyloid A4, constitutive | 11p15.1-p14 | 0.226 | 0.274 | 1.01e-08
|
ITGB8 | integrin, beta 8 | 7p15.3 | 0.226 | 0.43 | 0
|
TSFM | Ts translation elongation factor, mitochondrial | 12q14.1 | 0.226 | -0.119 | 0.0137
|
IL20 | interleukin 20 | 1q32 | 0.226 | 0.33 | 3.53e-12
|
BCL3 | B-cell CLL/lymphoma 3 | 19q13.1-q13.2 | 0.224 | 0.395 | 0
|
ACE2 | angiotensin I converting enzyme 2 | Xp22 | 0.224 | 0.327 | 5.67e-12
|
CFAP74 | cilia and flagella associated protein 74 | 1p36.33 | 0.223 | -0.308 | 9.18e-11
|
LCAT | lecithin-cholesterol acyltransferase | 16q22.1 | 0.223 | -0.153 | 0.00156
|
SNX3 | sorting nexin 3 | 6q21 | 0.222 | 0.292 | 8.82e-10
|
SEC22B | SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) | 1q21.1 | 0.221 | -0.066 | 0.171
|
PRCP | prolylcarboxypeptidase (angiotensinase C) | 11q14 | 0.221 | 0.279 | 5.34e-09
|
OLFM4 | olfactomedin 4 | 13q14 | 0.221 | 0.329 | 3.95e-12
|
IL1B | interleukin 1, beta | 2q14 | 0.221 | 0.381 | 1.88e-16
|
SLC35A5 | solute carrier family 35, member A5 | 3q13.13 | 0.221 | 0.228 | 2.15e-06
|
CD1E | CD1e molecule | 1q23.1 | 0.22 | 0.234 | 1.07e-06
|
ZFP69 | ZFP69 zinc finger protein | 1p34.2 | 0.218 | -0.294 | 7.35e-10
|
TRPM6 | transient receptor potential cation channel, subfamily M, member 6 | 9q21.13 | 0.217 | 0.379 | 3.29e-16
|
VSIG1 | V-set and immunoglobulin domain containing 1 | Xq22.3 | 0.217 | 0.264 | 3.57e-08
|
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 14q13 | 0.214 | 0.438 | 0
|
CDKL1 | cyclin-dependent kinase-like 1 (CDC2-related kinase) | 14q21.3 | 0.214 | 0.391 | 0
|
PSTPIP2 | proline-serine-threonine phosphatase interacting protein 2 | 18q12 | 0.214 | 0.337 | 1.21e-12
|
SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 7q21-q31 | 0.213 | 0.017 | 0.723
|
ZC3H12A | zinc finger CCCH-type containing 12A | 1p34.3 | 0.213 | 0.384 | 5.91e-17
|
FAM222A | family with sequence similarity 222, member A | 12q24.11 | 0.212 | -0.273 | 1.18e-08
|
NT5DC1 | 5'-nucleotidase domain containing 1 | 6q22.31 | 0.212 | 0.372 | 2.06e-15
|
IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 6q14.3 | 0.211 | 0.259 | 6.48e-08
|
NTN4 | netrin 4 | 12q22 | 0.209 | 0.181 | 0.00018
|
CCDC138 | coiled-coil domain containing 138 | 2q13 | 0.209 | -0.044 | 0.365
|
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 6q22.33 | 0.208 | 0.245 | 3.37e-07
|
GALNT16 | polypeptide N-acetylgalactosaminyltransferase 16 | 14q24.1 | 0.208 | -0.095 | 0.0499
|
PIGR | polymeric immunoglobulin receptor | 1q31-q41 | 0.208 | 0.198 | 3.79e-05
|
LAMB2P1 | laminin, beta 2 pseudogene 1 | 3p21.3-p21.2 | 0.204 | -0.215 | 8.15e-06
|
BBS2 | Bardet-Biedl syndrome 2 | 16q21 | 0.204 | 0.038 | 0.431
|
TMEM123 | transmembrane protein 123 | 11q22.1 | 0.201 | 0.283 | 2.95e-09
|
POT1 | protection of telomeres 1 | 7q31.33 | 0.201 | 0.136 | 0.00481
|
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 1q24.2 | 0.2 | 0.236 | 8.52e-07
|
IPCEF1 | interaction protein for cytohesin exchange factors 1 | 6q25.2 | 0.2 | 0.378 | 4.83e-16
|
CP | ceruloplasmin (ferroxidase) | 3q23-q25 | 0.2 | 0.349 | 1.56e-13
|
STEAP4 | STEAP family member 4 | 7q21.13 | 0.198 | 0.378 | 4.57e-16
|
ZBTB2 | zinc finger and BTB domain containing 2 | 6q25.1 | 0.197 | 0.299 | 3.3e-10
|
CHMP5 | charged multivesicular body protein 5 | 9p13.3 | 0.196 | 0.209 | 1.38e-05
|
COQ10B | coenzyme Q10B | 2q33.1 | 0.195 | 0.286 | 2.16e-09
|
C1RL | complement component 1, r subcomponent-like | 12p13.31 | 0.192 | 0.203 | 2.51e-05
|
FBF1 | Fas (TNFRSF6) binding factor 1 | 17q25.3 | 0.19 | 0.126 | 0.00904
|
CNOT7 | CCR4-NOT transcription complex, subunit 7 | 8p22-p21.3 | 0.19 | 0.055 | 0.257
|
NWD1 | NACHT and WD repeat domain containing 1 | 19p13.11 | 0.189 | 0.339 | 8.2e-13
|
OXCT2 | 3-oxoacid CoA transferase 2 | 1p34 | 0.189 | -0.273 | 1.19e-08
|
P3H2 | prolyl 3-hydroxylase 2 | 3q29 | 0.189 | 0.319 | 1.85e-11
|
PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta | 17q21.2 | 0.188 | -0.184 | 0.000132
|
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | 1p35.2 | 0.186 | -0.157 | 0.00118
|
EXOSC10 | exosome component 10 | 1p36.22 | 0.186 | -0.141 | 0.00364
|
DHRS7 | dehydrogenase/reductase (SDR family) member 7 | 14q23.1 | 0.186 | 0.208 | 1.46e-05
|
GALR2 | galanin receptor 2 | 17q25.3 | 0.185 | -0.274 | 1.05e-08
|
FBXO2 | F-box protein 2 | 1p36.21 | 0.184 | 0.071 | 0.144
|
METTL9 | methyltransferase like 9 | 16p12.2 | 0.18 | 0.11 | 0.023
|
HNF4G | hepatocyte nuclear factor 4, gamma | 8q21-q22 | 0.176 | 0.21 | 1.32e-05
|
FAM131C | family with sequence similarity 131, member C | 1p36.13 | 0.167 | -0.2 | 3.16e-05
|